WalthamSun Pharma plans $355 million acquisition of Checkpoint Therapeutics100% left coverage2 sources
WalthamSun Pharma plans $355 million acquisition of Checkpoint Therapeutics100% left coverage2 sources
Waltham, AcademiaBrandeis President Ron Liebowitz Resigns Amid Controversy100% center coverage2 sources
Waltham, AcademiaBrandeis President Ron Liebowitz Resigns Amid Controversy100% center coverage2 sources